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Abstract 
Background: Narrative reformulation (NR) is a component of cognitive analytic therapy 
(CAT) that is assumed to increase client engagement and improve clinical outcomes.  This 
study set out to test these claims.  Methods: A single-blind randomized and controlled 
dismantling trial investigated treatment outcomes for moderate to severely depressed patients 
receiving CAT in Primary Care. Ninety-five participants were randomized to either full-CAT 
(n=52) or CAT minus narrative reformulation (CAT-NR, n=43). Treatment duration in both 
arms was 8-sessions and was matched apart from the omission of the NR in the CAT-NR arm. 
The primary outcome measure was the Patient Health Questionnaire (PHQ-9), with secondary 
outcome measures of anxiety, functioning, helpfulness and the therapeutic alliance.  Outcomes 
were assessed at screening, every treatment session and at 8-weeks follow-up.  Results: Growth 
curve modelling found that NR did not enhance the efficacy of CAT for depression.  There 
were no significant differences between groups in terms of attendance, adverse events, anxiety, 
functioning, helpfulness or therapeutic alliance. There were large within-group effect sizes 
(d+>1.5), as CAT with or without NR produced significant reductions in depression (p<0.01). 
Limitations: The primary outcome were assessed via self-report and the follow-up period was 
brief.  Conclusions: These results suggest that NR may be redundant when treating depression 
with CAT.  Whilst a brief 8-session version of the CAT model appears suitable for treating 
depression in Primary Care, further research regarding the need for NR is indicated.   
Keywords: cognitive analytic therapy, deconstruction trial, depression 
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Whilst a large evidence base validates the efficacy of certain psychotherapies for 
depression (Cuijpers, Berking, Andersson, Quigley, Kleiboer, & Dobson, 2013), evidence 
identifying the specific and active ingredients of these effective treatments is scarce (Cuijpers, 
van Straten, Andersson, & van Oppen, 2008). The appropriate methodologies for identifying 
the active constituents of psychotherapies are deconstruction trials (Carrico & Antoni, 2008) 
or component analyses (Bell, Marcus & Goodlad, 2013). Such methodologies offer the 
opportunity to isolate causal relationships between therapy ingredients and outcomes 
(Borkovec & Sibrava, 2005) and allow conclusions to be drawn about the clinical need for 
specific treatment components or techniques (Czaja, Schultz, Lee, & Belle, 2003). 
µ'LVPDQWOLQJ¶WULDOVassess the efficacy of a treatment when a specific component is removed, 
ZKLOVWµDGGLWLYH¶WULDOVassess treatments with a specific component added (Ahn & Wampold, 
2001). For example, an early landmark dismantling trial by Jacobson et al. (1996) found that 
the behavioural activation component of cognitive behaviour therapy (CBT) produced 
equivalent outcomes to full CBT.  This study supported the application of behavioural 
activation as a stand-alone depression treatment (Mazzucchelli, Kane & Rees, 2009).  Meta-
analytic evidence illustrates that dismantling trials rarely yield any significant differences 
between study arms, whereas additive designs tend to yield small (but improved) treatment 
RXWFRPHV%HOO	'¶=XULOOD  
Cognitive analytic therapy (CAT) is a relational, integrative and time-limited 
psychotherapy informed by cognitive and psychodynamic theory/methods, which was 
specifically designed for use in pressured public services (Ryle & Kerr, 2002). Whilst CAT 
was initially developed in the UK, it is now practiced internationally, most notably in Ireland, 
Spain, Italy, Australia and Greece (Ryle, Kellett, Hepple & Calvert, 2014).  Treatment is 
typically delivered in 8, 16 or 24 session versions of the model allocated according to patient 
complexity (Ryle & Kerr, 2002). The analytical aspect of CAT concerns the concept of 
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reciprocal role dynamics (Ryle & Kerr, 2002), in which the patient inhabits and enacts (both in 
and out of therapy) unhelpful, limited and stereotyped roles, which are often formed as a result 
of early developmental abuse/neglect.  Roles can be self-self, self-other and other-self with the 
patient reversing between both ends of a reciprocal role (e.g. both criticising of self/others and 
eliciting criticism from others and also feeling put down/humiliated by the actions of others; 
summarised as a criticising to humiliated reciprocal role).  The cognitive aspect of the model 
(Ryle & Kerr, 2002) concerns procedural sequences of aim, thought, feeling, action and 
consequences that result from reciprocal role enactment. The cognitive and analytic aspects of 
the CAT model were initially theoretically integrated via the object relations procedural 
sequence model (Ryle, 1991) and then further assimilated via the multiple self-states model 
(MMSM; Ryle, 1997).   
CAT differs from cognitive-behavioural therapy for depression by taking a relational 
approach to symptomatology, working with the past, analysing enactments within the 
therapeutic relationship and associated analysis of habitual relationship patterns (Ryle & 
Kellett, 2017). The closest version of CBT to CAT would be schema therapy, as there is an 
emphasis during schema therapy on family history, developmental trauma and interpersonal 
relationships creating and maintaining distress (Young, Klosko & Weishaar, 2003).  A model 
of how change is accomplished and achieved during CAT for depression has been recently 
developed using task analysis (Sahu, Kellett & Hardy, 2017).  This model shows that change 
is typically achieved on the foundation stone of improved self-awareness of depressogenic 
reciprocal roles and associated procedures, WKURXJK WKH GHYHORSPHQW RI DQ µREVHUYLQJ VHOI¶
(Ryle & Kerr, 2002). The first tool used in CAT to facilitate greater self-awareness is narrative 
reformulation (NR). NR specifies the developmental origins of dysfunctional relational roles 
and patterns, highlighting possible enactments of such dysfunctional role procedures in the 
therapeutic relationship, identifying target problem procedures underlying/maintaining the 
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presenting problem, predicting reactions to termination and defining goals (Hamill, Reid & 
Reynolds, 2008). NR is presented in letter form, read to patients at the completion of 
assessment and patients are asked to review and then add to the NR (often as the first between-
session task) and a final version is agreed (Ryle & Kellett, 2017).  
NR has been proposed to be a central aspect of the CAT clinical method (Ryle & 
Kellett, 2017).  Whilst NR only takes one session to deliver, preparation (and associated clinical 
supervision) time is significant due to the complexity of the task (Denman, 2001). The validity 
of reformulation during CAT to accurately reflect reciprocal roles and target problem 
procedures has previously been illustrated in a case study using the core conflictual relationship 
theme method and structural analysis of social behaviour - cyclic maladaptive pattern 
assessments (Bennett & Parry, 1998). NR can evoke both strong positive and negative 
emotional responses in patients (Rayner, Thompson & Walsh, 2011). A negative emotional 
reaction to NR would be viewed as a potential enactment of a reciprocal role (i.e. the patient 
experiences NR as criticising and feels humiliated), rather than the NR being inherently wrong 
in itself (Ryle & Kellett, 2017).  NR has been widely assumed to be therapeutic in itself by 
lifting morale, strengthening therapeutic alliances via compassion, raising hope and focussing 
the treatment (Ryle, 1990; Ryle & Kerr, 2002). Qualitative evidence suggests that NR can help 
patients to feel accepted/understood, enhancing connections with self, the therapist and the 
therapy (Hamill et al. 2008).  However, evidence concerning the symptomatic impact of NR is 
mixed.  Two small studies (Evans & Parry, 1996; Shine & Westacott, 2010) failed to find any 
effect of NR on symptom amelioration. There has been evidence presented of sudden 
(beneficial) symptomatic change following NR in a case series of CAT for obsessive morbid 
jealousy (Curling, Kellett & Tottterdell, 2018) and during the single case experimental design 
evaluations of dissociative identity disorder, (Kellett, 2005), paranoid personality disorder 
(Kellett & Hardy, 2014), sex addiction (Kellett, Simmonds-Buckley & Totterdell, 2016) and 
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obsessive morbid jealousy (Curling, Kellett, Totterdell, Parry, Hardy & Berry, 2017). 
However, these small N studies are likely to be limited by selection biases and may not be 
representative of wider clinical populations.    
In view of the inconclusive evidence outlined above, this study sought to isolate and 
test the efficacy of NR during CAT, due to (a) NR being potentially draining of therapist time 
(Denman, 2001), (b) unresolved questions concerning the clinical utility of NR, (c) the lack of 
depression trials within the CAT evidence base (Calvert & Kellett, 2014) and (d) the extant NR 
evidence base being wholly based on small studies. The primary aim of this study was to assess 
(in a suitably powered study) whether NR is a specific active ingredient of CAT.  In order to 
achieve this aim, the study employed a dismantling deconstruction trial methodology (Bell, 
Marcus, & Goodlad, 2013). Therefore, treatment outcomes for depressed participants receiving 
treatment as usual (i.e. full-CAT), were contrasted with those who received CAT minus its 
narrative reformulation component (i.e. CAT-NR). The research is novel as the CAT evidence 
base does not contain any deconstruction trials. Study hypotheses were as follows: (1) 
participants in the full-CAT arm would achieve better depression outcomes and (2) experience 
a better therapeutic alliance and find therapy more helpful.   
Method 
Participants 
Ethical and research governance approvals were obtained from the English National Health 
Service (NRES reference number: 10/H0405/53) and the trial was registered (CT reference 
number: 10/H0405/53).  Participants were recruited and treated in a single Improving Access 
to Psychological Therapies (IAPT) service in the United Kingdom (UK), set in a socio-
economically deprived community.  IAPT services in the UK provide evidence-based 
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psychological therapies in Primary Care for anxiety and depression, using a stepped-care 
treatment model (Clark, 2011). General medical practitioners had initially diagnosed 
depression in potential participants, identified WKHQHHGIRUDµWDONLQJWUHDWPHQW¶DQGUHIHUUHG
them to the IAPT service. IAPT staff then allocated depressed patients to the trial after a 
screening appointment, with trial recruitment taking place via an initial study suitability 
meeting. The initial screening appointments were conducted by Psychological Wellbeing 
Practitioners, who are graduate workers in IAPT services that provide guided self-help 
interventions based on cognitive-behavioural theory. National curricula and associated 
assessment and treatment competency frameworks are available (UCL, 2015). PWPs are 
therefore specifically trained in the assessment of common mental health problems and make 
treatment recommendations as a routine aspect of their role (Firth, Barkham, Kellett & 
Saxon, 2015).  Trial screenings were completed by the research team and if the participant 
was suitable for the trial then they were provided with a study information leaflet explaining 
WKHGLVPDQWOLQJPHWKRGVRIWKHVWXG\LQOD\SHUVRQ¶VODQJXDJH.  In brief, participants were 
told that if they consented to participate in the trial they would be randomised to one of two 
arms (i.e. full treatment or treatment without a feedback letter from the therapist), and they 
would be blind to their allocation.  No participants refused to participate in the trial after 
reading the information leaflet.                     
Figure 1 details the flow of participants through the stages of the study and documents 
the reasons for trial exclusion. In total, n=125 were screened for study suitability, with n=95 
(76%) randomised (26 males and 69 females with an age range of 19-65) and n=30 (24%) 
excluded. Inclusion criteria were that the trial screening interview had to identify the presence 
of depression (interview conducted using DSM-IV criteria; American Psychiatric Association, 
1994) and participants needed to have clinical case-level depression symptoms (i.e. score 10-
21) on the Patient Health Questionnaire (PHQ-9, Spitzer, Kroenke & Williams, 1999). 
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Exclusion criteria were: a PHQ-9 score <10, not meeting DSM-IV diagnostic criteria for 
depression, significant ongoing risk issues (i.e. actively suicidal or currently self-harming), 
having a co-morbid anxiety disorder which was the primary reason for referral to treatment, 
reluctance to engage in psychotherapy, previous in-patient admission, significant amount of 
previous contact with mental health services (e.g. received services two or more times without 
any noted clinical change), visual impairment, non-English speaking, history of overdoses/self-
injury and current dependent substance use. Potential participants with a comorbid anxiety 
disorder were therefore excluded; this decision was informed by the recent systematic review 
of the CAT evidence base which highlighted the specific need to produce depression-specific 
clinical trials (Calvert & Kellett, 2014).      
Research design  
A single-blind randomised controlled deconstruction trial methodology was applied in this 
study (Bell, Marcus, & Goodlad, 2013).  Participants were allocated to two treatment arms by 
a researcher using parallel-group 1:1 randomisation stratified by therapist, using Graphpad 
6XUHVK¶VUHYLHZRIRQOLQHUDQGRPLVDWLRQUHVRXUFHVIRUFOLQLFDOWULDOVIRXQGWKDW
Graphpad produced unbiased randomisation sequences.  Once randomized, trial therapists 
offered 8-session CAT treatments and also conducted an 8-week follow-up review. The 
treatment study arms were either (1) full-CAT or (2) CAT-NR. In total, 52 (54.7%) participants 
were randomised to full-CAT and 43 (45.3%) were randomised to CAT-NR. Individual 
randomisation sequences were created for each therapist to minimise therapist effects and 
participants were blind to their allocation.    
Treatment model, fidelity and competence  
Treatment in both arms consisted of eight (50-minute) CAT sessions following the three-phase 
theoretical structure of CAT; reformulation, recognition and revision (Ryle & Kerr, 2002).  
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Apart from the NR manipulation, both treatment arms were matched and identical in terms of 
the elements considered fundamental to CAT. That is, an assessment phase (including 
completion of the psychotherapy file; Ryle, 1990) leading to a sequential diagrammatic 
reformulation (SDR), associated patient self-monitoring of identified roles and patterns 
(recognition), and a final stage of change-focussed work (revision), culminating in the 
exchange of goodbye letters by therapist and client at the last session. Figure 2 describes the 
core similarities and key difference between the study arms. The arms were matched in terms 
of the 8-session treatment contract. Seven (five female and two male) clinical psychologists 
and clinical psychology trainees in their final year of training delivered CAT following a 
treatment manual (Stockton, 2012). None of the trial therapists were fully accredited CAT 
therapists. A weekly 2-hour supervision group was provided and all patients were reviewed 
each week to ensure treatment integrity. A Consultant Clinical Psychologist and accredited 
CAT psychotherapist, supervisor and trainer facilitated all supervision groups. Competency 
was assessed during supervision using the Competency in Cognitive Analytic Therapy measure 
(CCAT; Bennett & Parry, 2004) from session audiotapes to encourage competency.  
Due to the focus of the research, treatment fidelity checks were performed on 
audiotapes of session 3 in both arms (i.e. the NR session in the full-CAT arm and the SDR 
session in the CAT-NR arm).  The coder (a qualified CAT therapist) was blind to allocation.  
In 100% of cases in the full-CAT arm, at session 3 an NR was read to the participant, discussed 
within the session and the participant asked to take the reformulation home in order to re-read, 
reflect upon and add to in terms of any missing or misplaced content.  In 100% of cases in the 
CAT-NR arm at session 3, the session included the construction of an SDR followed by the 
agreement of a between-session task which involved self-monitoring of the patterns and roles 
summarised by the SDR.  Ten recordings of third sessions from the CAT-NR and full-CAT 
arm were randomly selected for double-rating by another CAT therapist; agreement was 100%. 
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Additionally, eight participants (8.4%) had one treatment session rated for CAT competence 
by the author of the CCAT measure. Overall, the delivery of CAT treatment was deemed 
satisfactory, with an average rating across therapists of 25 (range 18-40). The cut-off score for 
CAT treatment fidelity is 20 (Bennett & Parry, 2004).  An RCT of CAT for personality disorder 
reported an average CCAT score of 22, with a range of 13-38 (Clarke, Thomas & James, 2013).   
Outcome measures; description and timing 
Attendance was recorded via accessing service records.  Adverse effects were recorded in terms 
of emergency psychiatric team input and in-patient admissions.  The following self-report 
measures were taken at screening, at each of the eight treatment sessions and again at 8-weeks 
follow-up. The Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001), 
Generalised Anxiety Disorder-7 (GAD-7; Spitzer et al., 2006) and Work and Social Adjustment 
Scale (WSAS; Mundt, Marks, Shear & Greist, 2002) were taken before each session and the 
WAI-S (WAI-S; Tracey & Kokotovi, 1989) and the HAT (HAT; Llewelyn, 1988) were taken 
after the session.    
Patient Health Questionnaire-9 (PHQ-9)  
This 9-item measure is a validated case-finding tool for major depressive disorder (Kroenke, 
Spitzer, & Williams, 2001). Scores on the PHQ-9 range from 0-27, a score of 10 is used as a 
cut-off to identify cases with diagnosable depression symptoms (Wittkampf et al., 2007). The 
PHQ-9 is based on DSM criteria for symptoms of major depression (Lowe et al., 2004) and is 
widely recognised as a valid and reliable measure of depressive symptoms (Martin et al., 2006).   
Generalized Anxiety Disorder-7 (GAD-7) 
This 7-item measure screens for the presence of generalized anxiety disorder and other anxiety 
problems such as panic disorder and post-traumatic stress. Summed scores range between 0 
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and 21 with a recommended cut-off RIfor the diagnosis of a clinically important anxiety 
disorder (Spitzer et al., 2006). The GAD-7 is recommended as a useful tool to assess and to 
monitor change in anxiety symptom severity (Gyani et al., 2013).   
Work and Social Adjustment Scale (WSAS)  
The WSAS measures the impact of mental health difficulties on aspects of daily functioning 
(Mundt, Marks, Shear & Greist, 2002). Scores on the WSAS range from 0 to 40, a higher score 
on the scale indicates a higher level of impaired functioning (Mataix-Cols et al., 2005). The 
WSAS has been previously used as a measure of functional impairment in Primary Care (Gyani 
et al., 2013).   
Working Alliance Inventory-Short (WAI-S)  
This measure assesses the strength of the therapeutic alliance across three subscales: agreement 
on therapy tasks, goal agreement and quality of the therapeutic bond (Tracey & Kokotovi, 
1989). The WAI-S has been found to have a good internal consistency (Smits et al, 2014) and 
predictive validity (Busseri & Tyler, 2003).  
Helpful Aspects of Therapy (HAT)  
This measure gathers TXDQWLWDWLYHDQGTXDOLWDWLYHLQIRUPDWLRQRQWKHSDWLHQW¶VSHUFHSWLRQVRI
the helpfulness during treatment sessions (Llewelyn, 1988). The HAT asks participants to 
describe both the most and least helpful aspects of the therapy session and then to rate the 
helpfulness/ unhelpfulness of the session (Llewelyn, 1988).  Participants rate how helpful or 
hindering the session is on a 1 to 9 Likert Scale with 1 being extremely hindering and 9 being 
extremely helpful.   
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Analysis strategy 
Primary outcome definition and sample size calculation 
The primary outcome was the PHQ-9 depression score at 8-weeks follow-up. Assuming a 
µPHGLXP¶HIIHFWVL]HRII DVLJQLILFDQFHlevel of alpha=.05 with two study arms 
providing data at three time points (NR, termination and follow-up) a total sample size of 
N=24 per group enabled 80% power to test for differences between full-CAT and NR-CAT. 
The sample of N = 95 therefore was adequately powered for the primary analysis.   
Primary analysis 
Analyses were conducted using SPSS v.24. Longitudinal multilevel modelling (MLM) was 
used to examine changes in depression (PHQ-9) symptoms over time, and to compare the rate 
of change (growth trends) between treatment groups at 8-weeks follow-up. A two-level model 
was applied; where session-by-session PHQ-9 scores (level 1) were nested within each case 
(level 2), including random intercepts and random slopes at level 2. This method appropriately 
modelled the repeated (and therefore autoregressive) outcome measurements, and had the 
additional advantage of being able to model growth trends over missing data-points, thus 
enabling best use of all available data following intention-to-treat principles. Following 
standard MLM guidelines (Singer & Willett, 2003), an unconditional (no predictors) model 
was initially examined to determine the variance explained at each level. We then examined 
alternative trends used to model changes over time (e.g., linear, quadratic, cubic and log-linear 
trends), and selected the best fitting model using í ORJ OLNHOLKRRG UDWLR WHVWV. After initial 
model checking, the main DQDO\VLVDSSOLHGDWZRဨOHYHOOLQHDU growth model, controlling for pre-
treatment PHQ-9 severity (mean-centred), entering the following predictors: group (CAT-NR 
vs. full-CAT), and a group * time interaction term. This interaction term was the main 
hypothesis test, since it compared linear changes over time between treatment groups. The 
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main MLM analysis was repeated in a sensitivity analysis additionally controlling for treatment 
sessions (mean-centred), to assess the robustness of the results, in case there were any 
systematic differences in treatment duration across groups.  
Secondary analyses 
The main MLM analysis was repeated including all data points up to session 4 (the session 
after the NR component was delivered), and then up to the end of the acute phase treatment 
(session 8). These MLM analyses were repeated to examine between-group differences in 
secondary outcome measures (GAD-7, WSAS). MLM was also used to compare linear growth 
trends in WAI-S and HAT scores between groups, but taking session 1 scores as covariates 
(since these measures were not completed pre-treatment) and examining changes after session 
3 (since this is when NR took place, and these measures were completed at the end of the 
session).  To assess treatment acceptability, three subsamples were created and compared 
between groups; (a) those who attended alOVHVVLRQVWHUPHGµIXOOWUHDWPHQWFRPSOHWHUV¶E
those who had attended 4-VHVVLRQVWHUPHGµSDUWLDOWUHDWPHQWFRPSOHWHUV¶DQGFWKRVHZKR
KDGDWWHQGHG OHVV WKDQVHVVLRQVµGURSRXWV¶ 0HDQVSDLUHGVDPSOH W-tests and associated 
effect sizes pre-post and screening-to-follow-up PHQ-9 outcomes were also calculated.  For 
all effect size calculations, the Cohen (1988) guidance was used of d+ > 0.20 being a small 
effect, d+ > 0.50 being a medium effect and d+ > 0.80 being a large effect.  
In order to compare individual treatment response rates in the arms, five depression 
outcome categories were created on pre-post and screening-to-follow-up PHQ-9 comparisons. 
The reliable change index (RCI; Jacobson & Traux, 1991) assessed whether change on PHQ-
9 scores were beyond chance variation or regression to the mean.  Outcome categories were 
µrecovered¶ UHOLDEOH LPSURYHPHQWSOXV FKDQJH IURPD FOLQLFDO FDVH WR D QRQ-clinical case), 
µimproved¶UHOLDEOHLPSURYHPHQWµpositive clinical change¶FKDQJHIURPDFOLQLFDOFDVHWRD
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non-FOLQLFDOFDVHµstasis¶DQRQ-UHOLDEOHFKDQJHLQHLWKHUGLUHFWLRQRUµdeteriorated¶UHOLDEOH
deterioration). McNemar tests examined differences between the outcome rates achieved by 
CAT-NR versus full-CAT, and were only employed if cell size was greater than 10 in each 
treatment arm sub-sample.  Treatment response was not analysed on an intention-to-treat basis, 
as patients who had dropped out prior to session 1 (n=5) and those lost to follow-up (n=28) 
were excluded from this analysis. 
Results 
Screening, suitability and treatment acceptability  
Pathways through treatment for the full-CAT and CAT-NR arms are summarised in the 
CONSORT diagram (see Figure 2).  Reasons for exclusion (n=30; 24%) were mainly due 
failure to meet diagnostic threshold for depression (n=10) and/or having a co-morbid anxiety 
disorder which was the primary reason for referral (n=10).  Ninety-five patients (76%) were 
randomised into either full-CAT (n=52; 54.8%) or CAT-NR (n=43; 45.2%). In the full-CAT 
arm 34% were unemployed or in receipt of a health related benefit in comparison to 32% in 
the CAT-NR arm.  In terms of attendance, in the full-CAT arm, 35 participants (67.3%) were 
full treatment completers, 7 (13.5%) partially completed treatment and 10 (19.2%) dropped-
out.  Fifteen participants (28.9%) in the full-CAT treatment arm were lost to follow-up, with 
n=37 (71.1%) completing the follow-up assessment.  In the CAT-NR arm, 27 patients (62.8%) 
fully completed treatment, 10 (23.3%) partially completed treatment and 5 (13.9%) dropped-
out.  In the CAT-NR arm, 13 (30.2%) patients were lost to follow-up, with n=30 (69.8%) 
completing follow-up. At follow-up, 3 patients (n=2 from the full-CAT arm and n=1 from 
CAT-NR arm) were referred onto further therapy (referred to CBT in each case).  No 
participants in either arm needed emergency psychiatric team input or in-patient admission 
during their contact time within the trial.  The study arms did not significantly differ in terms 
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of dropout (ʖϸ (1, N=95)=.468, p= .494), treatment completion (ʖϸ (1, N=95)= .468, p= .494), 
lost to follow-up (ʖϸ (1, N=95)=.022, p= .883) or completed follow-up rates (ʖϸ (1, N=95)=.022, 
p=.883).  
Randomisation checks and demographic characteristics  
Randomisation checks assessed for any potential demographic or symptomatic differences 
prior to treatment (see Table 1).  There were no age differences between the full-CAT (M=43.3, 
SD=11.8) and CAT-NR arms (M=39.3, SD=11.1). Gender was equally distributed across full-
CAT (24.5% male; 75.5% female) and CAT-NR (22.0% male; 78.0% female). Depression 
(PHQ-9) was equally moderately-severe at initial screening in the full-CAT (M=15.7, SD=5.1) 
and CAT-NR (M=14.3, SD=5.4) arms. There were no significant differences between the arms 
at screening in terms of anxiety, functioning, or initial session differences in session helpfulness 
or the working alliance ratings.   
Efficacy of narrative reformulation  
The MLM analysis results are summarised in Table 2 (full regression outputs are available in 
a supplementary appendix). There PHQ-9 model group * time interaction term was not 
statistically significant at treatment session 4 (B = 0.17, SE = 0.35, p = .63), at post-treatment 
% í0.07, SE = 0.20, p = .74) or at 8-weeks IROORZဨXS% í07, SE = 0.17, p = .67). The 
same results were obtained in a sensitivity analysis controlling for treatment duration 
(interaction term: % í0.07, SE = 0.17, p = .67, not shown in table). Similarly, no significant 
effects were observed for any of the secondary outcomes at any of the measurement points. 
The effect of CAT for depression in full-CAT and CAT-NR 
Table 3 reports the means, within-group effect sizes and t-test results for full-CAT and CAT-
NR on pre-post and screening-to-follow-up comparisons. Both treatment arms produced large 
16 
 
effect sizes (d+>1.5; Cohen, 1988); highly significant differences on pre-post and screening-to-
follow-up comparisons were apparent.  
Individual outcomes in full-CAT and CAT-NR   
Individual depression outcome category rates for full-CAT and CAT-NR are reported in table 
4. The recovery rate (i.e. a reliable and clinically significant improvement in depression) did 
not significantly differ between full-CAT (34.60% at termination and 38.50% at follow-up) 
and CAT-NR (44.20% at termination and 34.90% at follow-up).  At the end of treatment, 
significantly more participants in the CAT-NR arm had experienced a clinically significant 
reduction in depression (scores below diagnostic cut-off) and at follow-up significantly more 
participants in the full-CAT arm had a stasis outcome (no statistically reliable change).  
Discussion 
 
This research was novel in attempting to isolate and examine the clinical efficacy of an 
assumed active ingredient of CAT (i.e. narrative reformulation) during the treatment of 
depression in Primary Care. The study used a dismantling methodology in a suitably powered 
trial to achieve its aims, being a relatively rare example of dismantling studies in the field of 
depression treatment.  A particular strength of the study was that the adherence checks 
confirmed that the experimental component (NR procedure) was indeed present in the 
intervention arm and then absent in the control arm. Participants were moderately to severely 
depressed at intake according to the PHQ-9 categorisations and randomisation was effective at 
yielding balanced and equivalent groups prior to the intervention.  Therefore, subsequent 
comparisons of the two study groups were based on solid methodology, rationale and 
associated evidence of treatment adherence.   
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No significant differences in depression outcomes were found between groups at any 
stage of the therapy.  This would strongly indicate that NR is not an active ingredient of CAT 
treatment for depression. This suggests clinically that the efficiency of CAT could be improved 
(when working with depression) by removing the NR component and moving straight onto co-
constructing the sequential diagrammatic reformulation (SDR) after the initial assessment. The 
current findings also support the available meta-analytic evidence that dismantling trials are 
typically unlikely to yield any significant differences between study arms (Bell et al., 2013).  
Both treatment arms produced significant reductions in depression, and so fill an identified gap 
in the CAT evidence base (Calvert & Kellett, 2014).  There was no evidence that CAT with or 
without NR increased the likelihood of clinical deterioration; and the majority of patients 
recovered, improved or had a clinical positive change. On secondary outcomes, no significant 
differences were found between the two treatment arms following NR, at treatment termination 
or at follow-up in terms of anxiety outcomes, functional impairment, the therapeutic alliance 
or ratings of the helpfulness of therapy.  These results present a real challenge to CAT 
orthodoxy of NR being both therapeutic in itself and also strengthening the working alliance 
(Ryle & Kerr, 2002).  The results are consistent with other empirical evidence that NR has little 
impact on perceived helpfulness or the working alliance (Evans & Parry, 1996; Shine & 
Westacott, 2010).  An improvement on any replication efforts would be the addition of a 
measure of readiness to change (such as the URICA; Bergly, Stallvik, Nordahl & Hagen, 2014) 
to assess motivation as a potential moderator of NR during CAT.     
Sub-group analyses of the outcome data revealed some intriguing differences between 
the arms, albeit in smaller samples, so the results need to be interpreted with some caution.    
Participants who did not receive a narrative reformulation were more likely to have experienced 
a clinically significant reduction in depression by the end of treatment.  This effect may have 
been due to the CAT-NR group immediately progressing onto mapping the sequential 
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diagrammatic reformulation (SDR) following assessment and therefore entering the 
recognition and then revision stages (i.e. the active change work) of CAT earlier (Ryle & Kerr, 
2002).  However, this difference was not maintained at follow-up, with a significantly greater 
proportion of CAT-NR participants remaining in stasis in terms of depression outcome.  This 
alternatively suggests that NR may serve some protective function regarding the long-term 
management of depression, which is important considering the often high rates of relapse 
observed (Steinert, Hofmann, Kruse, & Leichsenring, 2014). Nevertheless, these subgroup 
analyses are limited by missing data (at 8-week follow-up), whereas the primary MLM 
analyses are better suited to cope with missing data and confirmed that there were no significant 
differences in depression changes over time.  In terms of safety, then no participants in either 
arm were admitted to an in-patient unit due to a deterioration in their depression or were 
referred to the psychiatric emergency team.  Similarly, on the primary outcome measure, there 
were no reliable deteriorations at end of treatment or at follow-up in either of the arms of the 
trial.  These results would imply that brief 8-session CAT can be safely delivered in Primary 
Care.  
This study suggests that this brief 8-session version of CAT is also µORQJHQRXJK¶WREH
effective at treating depression, despite being considerably shorter than typical 16 or 24-session 
CAT treatment protocols (Ryle & Kerr, 2002).  The CAT literature has previously lacked 
sufficient evidence to support the application of this brief version of the model (Calvert & 
Kellett, 2014). Effective but brief (efficient) psychological interventions are in demand in 
public services due to the need for ensuring and maintaining high patient throughput in 
pressured clinical services (Clark, 2009). The large within-group effect sizes observed in this 
study (d+>1.5) were larger than the Ryle et al. (2014) meta-analytic mean effect size (d+ 0.83) 
for CAT.  This is probably due to the Ryle et al. (2014) meta-analysis being mainly based on 
SHUVRQDOLW\ GLVRUGHU RXWFRPHV DQG WKHUHIRUH EDVHG LQ µKDUGHU WR KHOS¶ SRSXODWLRQV For 
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moderate-to-severe depression, 16 sessions of high intensity CBT is recommended for IAPT 
services (NICE, 2009), but the acceptability of CBT for some patients can be poor (Milosevic, 
Levy, Alcolado & Radomsky, 2015).  Despite the brevity of the CAT intervention, the recovery 
rates in this trial (34.9% to 44.2%) are comparable to rates observed across the controlled trials 
of CBT for depression (e.g. 49%, 95% CI: 0.32±0.66; Cuijpers et al., 2014). It is, however, 
possible that this recovery rate may be influenced by spontaneous remission in some cases. 
Spontaneous remission from major depression has been previously documented in meta-
analyses of data from control group participants (e.g., 20% reported by Posternak and Miller, 
2001). The development of a brief 8-session CAT model for depression potentially increases 
service plurality and patient choice in IAPT services in the UK. Given the acknowledged 
similarities between CAT and CBT, then CBT and schema therapy for depression have been 
compared to show that equivalent outcomes were achieved by both therapies, and in this trial 
both treatments delivered weekly sessions for 6 months, followed by monthly therapy sessions 
for 6 months (Carter et al. 2013). Furthermore, the dropout rate for both treatment arms 
combined was low (i.e. 16.8%) and treatment completion rates were high (i.e. 67.3% in full-
CAT and 62.8% in CAT-NR attended all eight sessions). This mirrors the CAT evidence base 
of consistently high treatment retention rates (Calvert & Kellett, 2014), and also compares 
favourably with the dropout rate for CBT outcome studies (26.2%; Fernandez, Salem, Swift, 
& Ramtahal, 2015).   
NR is acknowledged as a very time consuming process in the context of pressured 
clinical services (Denman, 2001).  Despite NR taking up just one clinical session, this obscures 
the amount of preparation time and supervision required. Without strong evidence for 
superiority of NR, the significant amount of time spent on NR may not be necessary to improve 
treatment outcomes when treating depression. Previous studies have suggested that NR may be 
an important treatment component when working with patients with highly complex 
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presentations (Kellett, 2005; Kellett & Hardy, 2014; Kellett et al. 2016; Curling et al. 2017; 
Curling et al. 2018).  However, previous studies have not applied a dismantling method, and 
therefore such claims are currently founded on weak evidence and in small samples.  It should 
also be noted that despite the trial being registered in a public database, registration was 
retrospective and this may be seen as a limitation.  The authors acknowledge that such 
retrospective registration does offer a strong assurance against biases such as selective outcome 
reporting.  In this regard, we note that the study findings are indeed contrary to our initial 
hypotheses, which were specified a-priori and subjected to scientific review ahead of 
conducting the trial, as part of the ethics approval process. The study protocol, thus did go 
through a scientific review process and the planned analyses reported here were planned and 
recorded publicly within the NHS approval process.  The original protocol did not plan growth 
curve modelling (which is the main analysis presented in this paper, as recommended by peer 
reviewers), and that addition to the results replaces the ANCOVA that was originally planned.   
A number of limitations should be considered when interpreting the present results.  
Previous authors have raised some concerns about the PHQ-9 measure in terms of lacking 
sensitivity to change and being somewhat brief and limited in terms of depth and breadth of 
assessment of depressive symptoms (Manea, Gilbody & McMillan, 2015).  The trial was 
conducted in an IAPT service and such services use the PHQ-9 as one of two primary outcome 
measures for depressed patients (Clark, 2009), and so it was decided to retain the measure in 
order to increase the external validity of the trial. IAPT services use a pre-specified and 
nationally consistent battery of outcomes measures (i.e. the PHQ-9, GAD-7 and the WSAS) 
and therefore despite potential participants with comorbid anxiety disorders being excluded, 
the GAD-7 was used a standard aspect of IAPT outcome monitoring.  The fact that the primary 
outcome measure (and the majority of secondary outcomes) were based on self-report and the 
follow-up period was short are acknowledged as study weaknesses. The battery of measures in 
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the trial would have benefited from the addition of a measure of symptom insight (Lincoln, 
Lüllmann & Rief, 2007).  Recommendations suggest that depression trials should measure 
treatment outcomes independently and also 18-months post treatment completion (NICE, 
2009). Extensive trial selection criteria were also employed, which reduces the generalisability 
of the findings (Rothwell, 2006) and particularly the decision to exclude participants with a 
comorbid anxiety disorder. It is acknowledged that in Primary Care setting that depression and 
anxiety often occur as a comorbid condition (Das-Munshi et al. 2008), but as highlighted in the 
method, the decision to exclude was based on the attempt to improve the focal evidence base 
in relation to CAT treatment of depression. The study did not exclude potential participants 
with psychotic, bipolar or psychotic presentations, because the context of the service in which 
the trial was conducted (i.e. an IAPT service) is commissioned to deliver evidenced-based 
psychological therapies for anxiety and depression (Clark, 2009).  Therefore, potential 
participants with these forms of comorbidity would be treated in another part of the service (i.e. 
Secondary Care).  Finally, therapists in the study were not fully accredited CAT practitioners, 
although they were trained and closely supervised by an expert and fully accredited CAT 
practitioner. Controlling for personality pathology would have been a useful addition to the 
method, because there is evidence in IAPT services that personality difficulties supress 
outcomes and recovery rates (Goddard, Wingrove & Moran, 2015).  Regardless of training, 
supervision support and evidence presented regarding model adherence and fidelity, and it is 
XQFOHDU ZKHWKHU WKHUDSLVWV¶ WUDLQLQJ VWDWXV PD\ KDYH DIIHFWHG WKH UHVXOWV (Roth, Pilling & 
Turner, 2010).  Whilst dropout rates were low in each arm, the reasons for dropout were not 
collected and this would be a valuable addition to future studies.        
To conclude, brief CAT for depression appears to be a safe and effective treatment 
option in IAPT and Primary Care services.  This sufficiently powered and controlled study has 
revealed little evidence that NR specifically enhanced depression outcomes, the working 
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alliance or perceived helpfulness of the therapy.  Findings have major clinical and service 
implications for the delivery of brief CAT and the role and function NR in the treatment of 
depression.  It would appear appropriate to now progress onto a head-to-head trial of CBT 
versus CAT for depression in IAPT services.  This would be particularly useful if the Goddard 
et al. (2015) evidence could be used to select patients with personality issues accessing IAPT 
services.  This research also serves as a prompt for future research focal to deconstructing the 
efficacy of case formulation during other psychotherapies. There may be a tendency to 
µRYHUYDOXH¶formulation which, despite clinician approval, is an activity that is not particularly 
well-grounded in scientific evidence (Bieling & Kuyken, 2003).  Overall, these findings 
suggest that a brief 8-session CAT intervention can be effective for treating depression and 
future controlled research is indicated regarding the role, impact and function of case 
formulation.  
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Figure 1  
CONSORT Diagram  
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Figure 2 
Description of treatment pathway in full-CAT and CAT-NR treatment arms. 
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Table 1.  
Pre-treatment full CAT and CAT-NR demographic and clinical characteristics 
 
 
Characteristic 
 
Full CAT (n = 
52) 
 
CAT-NR (n = 
43) 
 
t-testa 
 
p 
Age in years, mean 
(SD) 
43.3 (11.8) 39.3 (11.1) t(88)=1.643 .104 
Female (%) 75.5 78.0 ʖϸ (1, N=90)=.080 .777 
Measures     
  PHQ-9 mean (SD) 15.7 (5.1) 14.3 (5.3) t(91)=1.323 .189 
  GAD-7 mean (SD) 13.0 (6.1) 11.2 (5.6) t(91)=1.508 .135 
  WSAS mean (SD) 19.4 (8.6)c 17.7 (6.9)d t(88)=1.046 .299 
  WAI-S mean (SD)b 63.0 (15.0)e 64.0 (12.5)f t(81)= -.345 .731 
  HAT mean (SD)b 7.5 (1.8)g 6.9 (2.2)h t(47)= .919 .363 
 
aChi-square used to assess for significant gender differences between the treatment arms;        
b process measures necessarily taken at first therapy session; cN=49; dN=41; eN=43; fN=40; 
gN=26; hN=23. PHQ-9 = Patient Health Questionnaire-9; GAD-7 = Generalised Anxiety 
Disorder-7; WSAS = Work and Social Adjustment Scale; WAI-S = Working Alliance 
Inventory-Short Form; HAT = Helpful Aspects of Therapy    
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Table 2. Means, effect sizes, and multilevel modelling results for full CAT and CAT-NR on 
primary and secondary outcomes (N = 95) 
 
  
Within-group outcomes and analyses 
Between-group analyses 
(Full CAT vs CAT-NR) 
 
 
Sample and measures 
Full-CAT  
(n = 52) 
Mean (SD) 
 
 
ES 
CAT-NR 
(n = 43) 
Mean (SD) 
 
 
ES 
 
 
ES 
Fixed effects for group * 
time 
 
B, SE [95% CI] 
 
 
p 
PHQ-9 
       
Session 4 12.10 (6.11) 0.71 10.47 (6.27) 0.70 0.26 0.17, 0.35 [-0.53, 0.87] 0.63 
End of treatment 8.85 (6.62) 1.35 7.23 (5.90) 1.30 0.26 -0.07, 0.20 [-0.47, 0.33] 0.74 
Follow-up 8.80 (7.52) 1.36 7.47 (5.85) 1.26 0.20 -0.07, 0.17 [-0.41, 0.26] 0.67 
GAD-7 
       
Session 4 10.50 (5.31) 0.41 8.07 (5.79) 0.56 0.44 0.14, 0.33 [-0.51, 0.79] 0.66 
End of treatment 7.72 (5.56)b 0.87 5.65 (4.89) 1.00 0.40 -0.04, 0.18 [-0.39, 0.31] 0.81 
Follow-up 7.97 (6.46) 0.83 5.93 (5.11) 0.95 0.35 -0.05, 0.15 [-0.35, 0.26] 0.77 
WSAS        
Session 4 19.02 (16.23) 0.05 16.07 (7.94) 0.23 0.23 1.76, 0.91 [-0.04, 3.57] 0.06 
End of treatment 13.50 (9.47) 0.68 11.51 (8.36) 0.89 0.22 0.42, 0.33 [-0.23, 1.07] 0.20 
Follow-up 13.35 (10.40) 0.70 12.24 (7.92) 0.78 0.12 0.26, 0.30 [-0.35, 0.86] 0.40 
WAI-S        
Session 3 66.45 (13.24) 0.23 70.10(10.74) 0.49 0.30 -1.43, 1.13 [-3.68, 0.82] 0.21 
End of treatment 72.60 (9.50) 0.64 73.76 (8.18) 0.78 0.13 0.02, 0.41 [-0.79, 0.82] 0.97 
Follow-up 72.57 (9.62) 0.64 74.27 (8.24) 0.82 0.19 0.02, 0.41 [-0.79, 0.82] 0.97 
HAT        
Session 3 7.82 (1.48) 0.18 7.89 (1.38) 0.45 0.05 -0.77, 0.51 [-1.78, 0.24] 0.14 
End of treatment 8.08 (1.32) 0.32 7.54 (2.42) 0.29 0.28 -0.03, 0.14 [-0.32, 0.26] 0.82 
Follow-up 8.08 (1.35) 0.32 7.57 (2.44) 0.30 0.26 -0.03, 0.14 [-0.32, 0.26] 0.82 
 
Notes: ES = effect size; B = regression coefficient; SE = standard error; 95% CI = confidence intervals for B 
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Figure 3 
Full-CAT versus CAT-NR session-by-session depression (PHQ-9) mean scores. 
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Figure 4 
Full-CAT versus CAT-NR session-by-session depression (PHQ-9) linear growth trends and 
95% confidence intervals. 
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Table 3  
Pre-post and screening-to-follow-up PHQ-9 comparisons.  
Group Session 1 
mean (SD) 
Session 8  
mean (SD) 
Effect size (d) t-value  
Full-CAT 15.7(5.1) 6.9(5.4) d = 1.68 t(38)= 9.939 
 p = <.001* 
CAT-NR 14.3(5.4) 6.0(4.7) d = 1.63 t(35)= 6.933 
 p = <.001* 
 Screening 
mean (SD) 
Follow-up 
mean (SD) 
Effect size (d) t-value  
Full-CAT 15.7(5.1) 7.5(7.4) d = 1.29 t(35)= 8.515 
p = <.001* 
CAT-NR 14.3(5.4) 6.7(6.4) d = 1.28 t(29)= 5.939 
 p = <.001* 
* p = significant < 0.001 
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Table 4.  
Recovery rates full-CAT and CAT-NR at the end of treatment and at follow-up 
 
 Within-group outcomes Between-group 
outcomes 
(Full CAT vs CAT-NR) 
 Full-CAT 
(n; %) 
CAT-NR 
(n; %) 
McNemar 
value (n = 
95) 
 
p 
End of treatment PHQ-9 
outcome status 
    
Recovered 
Improved 
Clinically significant change  
Stasis 
Deteriorated  
18 (34.6) 
24 (46.2) 
29 (55.8) 
17 (32.7) 
0 (0.0) 
19 (44.2) 
20 (46.5) 
33 (76.7) 
9 (20.9) 
0 (0.0) 
0.60 
0.00 
8.31 
2.52 
.44 
1.00 
0.04* 
.112 
Follow-up PHQ-9 outcome 
status  
    
Recovered 20 (38.5) 15 (34.9) 1.31 .25 
Improved 26 (50.0) 17 (39.5) 0.00 1.00 
Clinically significant change  28 (53.8) 28 (68.1) 3.35 .067 
Stasis 18 (34.6) 13 (30.2) 6.61 .001* 
Deteriorated  0 (0.0) 0 (0.0)   
Note. *p<.05 
